2023 WHO data noted that 5 countries in the WHO African and Eastern Mediterranean Regions stopped preventive chemotherapy after impact assessments demonstrated an STH prevalence <2%.
These countries showcase the effectiveness of STH control efforts in reducing its prevalence.
